Segall Bryant & Hamill LLC raised its position in shares of Innophos Holdings, Inc. (NASDAQ:IPHS) by 10.8% during the 1st quarter, HoldingsChannel.com reports. The firm owned 1,090,307 shares of the specialty chemicals company’s stock after acquiring an additional 105,965 shares during the period. Innophos accounts for 1.0% of Segall Bryant & Hamill LLC’s investment portfolio, making the stock its 26th biggest position. Segall Bryant & Hamill LLC owned 0.06% of Innophos worth $43,841,000 at the end of the most recent quarter.
Other large investors have also recently made changes to their positions in the company. Ramsey Quantitative Systems acquired a new stake in Innophos during the 4th quarter valued at $134,000. Vident Investment Advisory LLC acquired a new stake in Innophos during the 4th quarter valued at $201,000. Alps Advisors Inc. acquired a new stake in Innophos during the 4th quarter valued at $213,000. GW&K Investment Management LLC acquired a new stake in Innophos during the 1st quarter valued at $222,000. Finally, Verition Fund Management LLC acquired a new stake in Innophos during the 1st quarter valued at $237,000. 95.27% of the stock is currently owned by institutional investors.
Shares of NASDAQ IPHS traded up $0.13 during mid-day trading on Thursday, reaching $48.59. The company had a trading volume of 459 shares, compared to its average volume of 126,213. Innophos Holdings, Inc. has a twelve month low of $38.66 and a twelve month high of $51.34. The company has a current ratio of 3.22, a quick ratio of 1.70 and a debt-to-equity ratio of 1.03. The company has a market capitalization of $959.44 million, a PE ratio of 19.75 and a beta of 0.83.
Innophos (NASDAQ:IPHS) last posted its quarterly earnings results on Tuesday, May 1st. The specialty chemicals company reported $0.61 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.55 by $0.06. Innophos had a net margin of 2.95% and a return on equity of 14.26%. The business had revenue of $205.00 million for the quarter, compared to the consensus estimate of $196.91 million. During the same period in the prior year, the business posted $0.59 earnings per share. Innophos’s revenue for the quarter was up 23.5% compared to the same quarter last year. analysts predict that Innophos Holdings, Inc. will post 2.7 EPS for the current year.
The business also recently declared a quarterly dividend, which was paid on Tuesday, June 5th. Stockholders of record on Friday, May 18th were paid a $0.48 dividend. This represents a $1.92 dividend on an annualized basis and a dividend yield of 3.95%. The ex-dividend date was Thursday, May 17th. Innophos’s dividend payout ratio (DPR) is presently 78.05%.
Several analysts have issued reports on the stock. BidaskClub raised shares of Innophos from a “hold” rating to a “buy” rating in a research note on Wednesday, June 6th. TheStreet raised shares of Innophos from a “c+” rating to a “b” rating in a research note on Wednesday, May 30th. Finally, Zacks Investment Research raised shares of Innophos from a “hold” rating to a “buy” rating and set a $51.00 target price on the stock in a research note on Wednesday, May 9th.
Innophos Holdings, Inc, together with its subsidiaries, produces specialty ingredients with applications in food, health, nutrition, and industrial markets. It operates through three segments: Food, Health and Nutrition; Industrial Specialties; and Other. The company's specialty ingredients include specialty phosphate salts and specialty phosphoric acids, as well as other mineral, enzyme, and botanical based specialty ingredients that are used as flavor enhancers in beverages; electrolytes in sports drinks; texture modifiers in cheeses; leavening agents in baked goods; calcium and phosphorus fortification in food and beverages; moisture and color retention in seafood, poultry, and meat; excipients in vitamins, minerals, nutritional supplements, and pharmaceuticals; and abrasives in toothpaste.
Want to see what other hedge funds are holding IPHS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innophos Holdings, Inc. (NASDAQ:IPHS).
Receive News & Ratings for Innophos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos and related companies with MarketBeat.com's FREE daily email newsletter.